Cargando…

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries

PURPOSE: To assess the sensitivity of cervical cytology to cancer by pooling individual patient cytology results from cancers diagnosed in studies that assessed cervical screening in low- and middle-income countries. METHODS: Two authors reviewed studies identified through PubMed and Embase database...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castanon, Alejandra, Landy, Rebecca, Michalopoulos, Dimitrios, Bhudia, Roshni, Leaver, Hannah, Qiao, You Lin, Zhao, Fanghui, Sasieni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2017
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646897/ https://www.ncbi.nlm.nih.gov/pubmed/29094092 http://dx.doi.org/10.1200/JGO.2016.008011

Ejemplares similares

Cervical cytology and the diagnosis of cervical cancer in older women
por: Landy, Rebecca, et al.
Publicado: (2015)

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review
por: Lim, Anita WW, et al.
Publicado: (2016)

Evaluating cytology for the detection of invasive cervical cancer
por: Landy, R., et al.
Publicado: (2015)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
por: Castanon, Alejandra, et al.
Publicado: (2017)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Cervical cancer in low and middle-income countries
por: Hull, Rodney, et al.
Publicado: (2020)

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?
por: Castanon, Alejandra, et al.
Publicado: (2018)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
por: Lorincz, Attila T, et al.
Publicado: (2013)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
por: Castanon, A, et al.
Publicado: (2013)

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study
por: Castanon, Alejandra, et al.
Publicado: (2014)

audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening
por: Falcaro, Milena, et al.
Publicado: (2023)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial
por: Castañon, A, et al.
Publicado: (2012)

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country
por: Vale, Diama Bhadra, et al.
Publicado: (2021)

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries
por: Campos, Nicole G., et al.
Publicado: (2016)

Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment?
por: Castañon, A, et al.
Publicado: (2015)

Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review
por: Zhang, Dongyu, et al.
Publicado: (2020)

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study
por: Castanon, Alejandra, et al.
Publicado: (2021)

Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery
por: LaVigne, Anna W., et al.
Publicado: (2017)

Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries
por: Gyawali, Bishal, et al.
Publicado: (2016)

Cervical Precancer Treatment in Low- and Middle-Income Countries: A Technology Overview
por: Maza, Mauricio, et al.
Publicado: (2016)

A Call for Low- and Middle-Income Countries to Commit to the Elimination of Cervical Cancer
por: Duncan, Jacqueline, et al.
Publicado: (2021)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review
por: Castanon, Alejandra, et al.
Publicado: (2021)

Cervical Cancer Prevention Through HPV Vaccination in Low- and Middle-Income Countries in Asia
por: Toh, Zheng Quan, et al.
Publicado: (2017)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

Nonneoplastic Cervical Cytology
por: Kamal, Meherbano, et al.
Publicado: (2022)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Cervical Cancer Prevalence, Incidence and Mortality in Low and Middle Income Countries: A Systematic Review
por: Shrestha, Aamod Dhoj, et al.
Publicado: (2018)

Prevention of cervical and breast cancer mortality in low- and middle-income countries: a window of opportunity
por: de Sanjose, Silvia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cfru1jjluqcpjhenf8v1be6brs